JCOGP
Journal of Controversies in Obstetrics & Gynecology and Pediatrics

As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance.

eISSN: 2980-0579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Elevated values in preeclampsia: diagnostic and prognostic role of NT-proBNP and ANP
Abstract
The aim of this review is to summarize the current understanding of the cardiac dimension of preeclampsia as reflected in the PubMed database, and to provide a perspective on how NT-proBNP and ANP may play a role in the future management of this challenging condition. Preeclampsia is a condition characterized by hypertension that typically develops after the 20th week of gestation. The most widely accepted model explaining the underlying pathology posits that disease progression involves two stages: placental insufficiency in the first stage and a maternal systemic response in the second. In the complex pathogenesis of preeclampsia, impaired cardiovascular adaptation and the resulting myocardial stress have been increasingly recognized as critical components. In this context, N-terminal pro–brain natriuretic peptide (NT-proBNP) and atrial natriuretic peptide (ANP)—biological indicators of cardiomyocyte stress and hemodynamic load—warrant careful investigation for their potential clinical applications. Data were analyzed from studies indexed in the PubMed database that compared the cardiac biomarkers NT-proBNP and ANP, examined their roles, and reported related outcomes in the context of preeclampsia. NT-proBNP primarily serves as a marker of increased ventricular afterload, whereas ANP is more indicative of diastolic dysfunction and atrial stretch. The observation that both biomarkers are significantly elevated in patients with preeclampsia, correlate with disease severity, and have the potential to predict adverse maternal outcomes underscores their clinical relevance in this condition. Multiple studies have demonstrated that both NT-proBNP and ANP levels are significantly elevated in preeclamptic pregnancies compared with healthy normotensive controls.

Keywords : Preeclampsia, hypertension, brain natriuretic peptide, atrial natriuretic peptide

Download Article


1. Brown MA, Magee LA, Kenny LC, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1): 24-43. doi:10.1161/HYPERTENSIONAHA.117.10803
2. Bokuda K, Ichihara A. Preeclampsia up to date—what’s going on? Hypertension Res. 2023;46(8):1900-1907. doi:10.1038/s41440-023-01323-w
3. Yu C, Lv H, Fang W, Zhang X, Huang L. Global incidence of maternal sepsis: a systematic review and meta-analysis.J Gynecol Obstet Hum Reprod. 2025;102940. doi:10.1016/j.jogoh.2025.102940
4. Masterson JA, Adamestam I, Beatty M, et al. Measuring the impact of maternal critical care admission on short-and longer-term maternal and birth outcomes.Intensive Care Med.2024;50(6):890-900. doi:10. 1007/s00134-024-07417-4
5. Koulouraki S, Paschos V, Pervanidou P, Christopoulos P, Gerede A, Eleftheriades, M. Short-and long-term outcomes of preeclampsia in offspring: review of the literature.Children.2023;10(5):826. doi:10.3390/children10050826
6. Yang M, Wang M, Li N. Advances in pathogenesis of preeclampsia.Arch Gynecol Obstet.2024;309(5):1815-1823. doi:10.1007/s00404-024-07393-6
7. Jin J, Gao L, Zou X, et al. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res. 2022;131(6):492-506. doi:10.1161/CIRCRESAHA.122.320771
8. Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol.2022;226(2):S1019-S1034. doi:10.1016/j.ajog.2020.10.022
9. Dupont V, Berg AH, Yamashita M, et al. Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway. J Clin Invest. 2022;132(20):e158346. doi:10. 1172/JCI158346
10. Islam MM, Takeyama N. Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances.Int J Mol Sci. 2023;24(21):15805. doi:10.3390/ijms242115805
11. Staff AC, Braekke K, Johnsen GM, Karumanchi SA, Harsem NK. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.Am J Obstet Gynecol. 2007;197(2):176-e1. doi:10.1016/j.ajog.2007.03.036
12. Zhang LX, Cao,JY, Zhou XJ. Construction and validation of a nomogram prediction model for the risk of new-onset atrial fibrillation following percutaneous coronary intervention in acute myocardial infarction patients.BMC Cardiovasc Disord.2024;24(1):642. doi:10. 1186/s12872-024-04326-8
13. Yasoda A. Physiological and pathophysiological effects of C-type natriuretic peptide on the heart.Biology.2022;11(6):911. doi:10.3390/biology11060911
14. Coats AJ, Anker SD, Lund LH, et al. Patiromer for heart failure medication optimization in patients with current or past hyperkalemia: DIAMOND subanalysis.Heart Failure.2024;12(12):2026-2037. doi:10. 1016/j.jchf.2024.08.003
15. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.J Clin Invest.1991;87(4):1402-1412. doi:10.1172/JCI 115146
16. Sabbatinelli J, Giuliani A, Bonfigli AR, et al. Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study.Cardiovasc Diabetol. 2022;21(1): 180. doi:10.1186/s12933-022-01616-3
17. Resnik JL. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women.Am J Obstet Gynecol.2005;193:450-454. doi:10.1016/j.ajog.2004.12.006
18. Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia.Am J Obstet Gynecol.2022;226(2):S988-S1005. doi:10. 1016/j.ajog.2021.11.022
19. Pillai AA, Thiyagarajan M, Sharma DK, et al. Maternal cardiovascular dysfunction in women with early onset preeclampsia: a cross-sectional study. J Matern Fetal Neonatal Med.2022;35(25):8394-8399. doi:10.1080/ 14767058.2021.1974834
20. Pellegrino A, Toncelli L, Pasquini L, et al. Left ventricular remodeling in twin pregnancy, noninvasively assessed using hemodynamic forces and pressure-volume relation analysis: prospective, cohort study.Am J Physiol Heart Circ Physiol. 2024;326(2):H426-H432. doi:10.1152/ajpheart. 00699.2023
21. Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure.Heart Fail Rev.2022;27(2):625-643. doi:10.1007/s10741-021-10105-w
22. Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruç, N. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy.J Perinat Med. 2005;33(2):121-124. doi:10. 1515/JPM.2005.023
23. Suciu VE, Leucu?a DC, Malu?an AM, et al. NT-proBNP and BNP as biomarkers for preeclampsia: a systematic review and meta-analysis.Int J Mol Sci.2005;26(13):6272. doi:10.3390/ijms26136272
24. Borghi C, Degli Esposti D, Immordino V, et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia.Am J Obstet Gynecol.2000;183(1):140-147. doi:10.1067/mob.2000.105684
25. Pretorius T, Van Rensburg G, Dyer RA, Biccard BM. The influence of fluid management on outcomes in preeclampsia: a systematic review and meta-analysis.Int J Obstet Anesth. 2018;34:85-95. doi:10.1016/j.ijoa. 2017.12.004
26. Bakacak M, Serin S, Ercan O, Köstü B, Bakacak Z, Kiran H. Association of serum N-terminal pro-brain natriuretic peptide levels with the severity of preeclampsia.J Matern Fetal Neonatal Med. 2016;29(17): 2802-2806. doi:10.3109/14767058.2015.1104663
27. Adam B, Malatyalioglu E, Alvur M, Kökçü A, Bedir A. Plasma atrial natriuretic peptide levels in preeclampsia and eclampsia.J Matern Fetal Investig. 1998;8(2):85-88.
28. Álvarez-Fernández I, Prieto B, Rodríguez V, Ruano Y, Escudero AI, Álvarez FV. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia.Clin Chim Acta.2016;463:150-157. doi:10.1016/ j.cca.2016.10.033
29. Nan MN, Garrido-Giménez C, Garcia-Osuna Á, et al. N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications.Ultrasound Obstet Gynecol. 2025;65(4): 447-455. doi:10.1002/uog.29202
30. Reyna-Villasmil E, Mejia-Montilla J, Reyna-Villasmil N, et al. Plasmatic levels of N-terminal pro-atrial natriuretic peptide in preeclamptic patients and healthy normotensive pregnant women.Med Clin (Barc). 2018;150(9):336-340. doi:10.1016/j.medcle.2017.06.048
31. Lafuente-Ganuza P, Carretero F, Lequerica-Fernández P, et al. NT-proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery.Clin Chem Lab Med. 2021;59(6):1077-1085. doi:10.1515/cclm-2020-1450
32. Hoevelmann J, Muller E, Azibani F, et al. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM). Clin Chem Lab Med.2021;110(8):1259-1269. doi:10.1007/s 00392-021-01808-z
Article available in :
Volume 4, Issue 1, 2026
Page : 7-14
https://doi.org/10.51271/JCOGP-0065
Article Information
Received : 11 Kas 2025
Accepted : 26 Oca 2026
Published : 31 Oca 2026
Corresponding Author :

Emre Uysal: Department of Obstetrics and Gynecology, Ereğli State Hospital, Konya, Turkiye

[email protected]
Citation : Uysal E, Mert A. Elevated values in preeclampsia: diagnostic and prognostic role of NT-proBNP and ANP. J Controv Obstetr Gynecol Ped. 2026;4(1):7-14.

Read: 49
Download : 33
Cited: 0
_Footer